Treatment With Levonorgestrel-Dispensing IUD Appeared To Be Effective, Safe For Women With Stage I Endometrial Adenocarcinoma Or Endometrial Hyperplasia With Atypia

Healio  (3/26, Lawrence) reported, “Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.” The study results “showed two-thirds of women had no signs of cancer or precancer in biopsies 6 months after insertion of the intrauterine device (IUD).” The findings were presented at the Society of Gynecologic Oncology (SGO) 2021 Annual Meeting on Women’s Cancer. HealthDay  (3/26, Murez) also reported.